Given the plasma GLP‐1 level and its receptor expression are decreased in T2D [21, 22], it is plausible that the combination of heightened glucose‐induced ChREBP activity and compromised GLP‐1 signaling contributes to the decreased expression of SNAP25 in diabetic β‐cells. Here, MLXIPL is linked to type 2 diabetes mellitus.